Evidence map›Paper›PMID 36311617›Full record

ArticleFrontiers in public health2022

SARS-CoV-2 Transmission Prevention Model Application in a Large Retail Company Before the Vaccine Introduction.

Ermanno Vitale, Francesca Vella, Giuliano Indelicato, Andrea Canalella, Salvatore Briguglio, Veronica Pittari, Paola Senia, Denis Vinnikov, Daniele Floresta, Venerando Rapisarda and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ermanno VitaleDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Francesca VellaDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Giuliano IndelicatoDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Andrea CanalellaDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Salvatore BriguglioDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Veronica PittariDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Paola SeniaDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Denis VinnikovDepartment of Epidemiology, Biostatistics and Evidence-Based Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Daniele FlorestaHealth and Safety Manager of Eurospin Sicily and Calabria, Catania, Italy.
Venerando RapisardaDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.
Veronica FilettiDepartment of Clinical and Experimental Medicine, Occupational Medicine, University of Catania, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On 11 March 2020, following the spread of SARS-CoV-2, WHO declared a pandemic status. The impact on national health and economic systems has been huge. Therefore, many countries took measures to restrict the spread of the virus. Many work activities have been subjected to lockdown measures. However, some production activities, continued to remain open, i.e., large-scale food distribution, food industry, pharmacies, hospitals, etc. In order to contain the spread of the pandemic, public health measures have been implemented by the States to reduce the contagion of the virus in the workplace. Therefore, it was important to implement measures to contrast and contain the spread of SARS-CoV-2/COVID-19 in workplaces. The aim of this study was to adopt and implement a safety protocol useful to restrict the spread of SARS-CoV-2 in a large-scale retail trade company located in the south of Italy, before vaccination, during the first and second pandemic phases also exploiting telemedicine services. Antibody serological test cards were also used during the first pandemic wave and rapid antigenic swabs during the second to detect workers positive for SARS-CoV-2. A population of subjects who worked for another company similar for production activity and distribution on the territory was selected as the control group. During work activities, this group followed the minimum activity protocol provided by the Italian legislation (24 April 2020, Ministry Protocol), which provided the daily monitoring of the body temperature and in the case of SARS- CoV-2 positive subjects the extraordinary sanitation of the workplace. The measures implemented identified the positive subject for SARS-CoV-2 at an early stage. The protocol made it possible to significantly reduce the spread of the virus within large-scale retail distribution, and therefore, to avoid the temporary closure of the stores with a consequent reduction of economic losses compared with the control group.

Indexed as

COVID-19VaccinesCommunicable Disease ControlHumansPandemicsSARS-CoV-2VaccinesCOVID-19SARS-CoV-2SARS-CoV-2 preventiontelemedicinetransmission prevention modelworkplace

Identifiers

PMID36311617
PMCPMC9616115

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.